Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
D 16.34 -0.24% -0.04
TEVA closed down 0.24 percent on Thursday, July 18, 2024, on 1.12 times normal volume. It ran into resistance at its 50 day moving average.
Earnings due: Jul 31
*** please verify all earnings dates ***
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -0.24%
Fell Below 50 DMA Bearish -0.24%
MACD Bearish Signal Line Cross Bearish -0.24%
Down 3 Days in a Row Weakness -0.24%
Fell Below 20 DMA Bearish -1.86%

   Recent Intraday Alerts

Alert Time
Outside Day about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
50 DMA Resistance about 22 hours ago
20 DMA Resistance about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Teva Pharmaceutical Industries Description

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Pain Drugs Medication Pharmaceutical Products Lymphoma Parkinson's Disease Opioids Allergy Leukemia Asthma Multiple Sclerosis Hormones MRI Cholesterol Active Pharmaceutical Ingredients Pharmaceutical Industries Fertility Sleep Apnea Treatment Of Parkinson's Disease Chronic Lymphocytic Leukemia Lymphocytic Leukemia Obstructive Sleep Apnea Narcolepsy Immunosuppressants Infertility Birth Control Blood Cells Chemical Entities Generic Pharmaceutical Red Blood Cell Chronic Myeloid Leukemia Teva Pharmaceutical Industries Urinary Incontinence Fentanyl Hot Flash Muscle Spasm Party Products Treatment Of Chronic Lymphocytic Leukemia Bronchial Asthma Contraception Generic Pharmaceutical Products Menopause Muscle Relaxants Nasal Allergy Oncogene

Is TEVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.69
52 Week Low 8.055
Average Volume 10,225,310
200-Day Moving Average 12.72
50-Day Moving Average 16.64
20-Day Moving Average 16.59
10-Day Moving Average 16.64
Average True Range 0.50
RSI (14) 46.24
ADX 17.81
+DI 20.15
-DI 25.10
Chandelier Exit (Long, 3 ATRs) 15.99
Chandelier Exit (Short, 3 ATRs) 17.13
Upper Bollinger Bands 17.34
Lower Bollinger Band 15.85
Percent B (%b) 0.33
BandWidth 8.97
MACD Line 0.04
MACD Signal Line 0.08
MACD Histogram -0.0389
Fundamentals Value
Market Cap 18.32 Billion
Num Shares 1.12 Billion
EPS -0.50
Price-to-Earnings (P/E) Ratio -32.68
Price-to-Sales 0.93
Price-to-Book 1.79
PEG Ratio 1.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.20
Resistance 3 (R3) 17.29 17.08 17.06
Resistance 2 (R2) 17.08 16.86 17.04 17.01
Resistance 1 (R1) 16.71 16.72 16.61 16.63 16.96
Pivot Point 16.51 16.51 16.45 16.46 16.51
Support 1 (S1) 16.14 16.29 16.03 16.05 15.72
Support 2 (S2) 15.93 16.15 15.89 15.67
Support 3 (S3) 15.56 15.93 15.62
Support 4 (S4) 15.48